Epstein Secrets

esidency can be." In a New York Times <https://www.nytimes.corn/2020/11/13/opinion/sunday/transition-national-security.html> (11/13, 18.61M) op-ed, Susan Rice, a member of the Biden-Harris transition advisory board but not of the transition team, asserted that in the week "since...Biden's victory became cl

s, Procter & Gamble Global Government Relations & Public Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and

nation campaign, the more seamless the transition from a Biden presidency to a Trump presidency can be." In a New York Times (11/13, 18.61M) op-ed, Susan Rice, a member of the Biden-Harris transition advisory board but not of the transition team, asserted that in the week "since...Biden's victory became c

s, Procter & Gamble Global Government Relations & Public Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and

nation campaign, the more seamless the transition from a Biden presidency to a Trump presidency can be." In a New York Times (11/13, 18.61M) op-ed, Susan Rice, a member of the Biden-Harris transition advisory board but not of the transition team, asserted that in the week "since...Biden's victory became c

s, Procter & Gamble Global Government Relations & Public Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and

nation campaign, the more seamless the transition from a Biden presidency to a Trump presidency can be." In a New York Times (11/13, 18.61M) op-ed, Susan Rice, a member of the Biden-Harris transition advisory board but not of the transition team, asserted that in the week "since...Biden's victory became c

s, Procter & Gamble Global Government Relations & Public Policy Associate Director Tara Hogan Charles, AstraZeneca Microbial Sciences Vice President Dr Mark Esser, McCain Institute Board of Trustees Chair Cindy McCain, former USAID COVIC-19 Task Force Executive Director Dr Ken Staley, and USGLC President and